Revvity Inc. (NYSE: RVTY)

https://www.revvity.com

At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionising what’s possible in healthcare, with specialised focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With 2022 revenue of more than $3 billion and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. *

	Start	2023-03-09 renamed
	Group	Revvity (Group)
	Predecessor	PerkinElmer Inc. (NYSE: PKI)
	Industry	cell line development (recombinant protein production)
	Industry 2	drug screening (service)

	Region	Waltham, MA
	Country	United States (USA)
	Street	940 Winter Street
	City	02451 Waltham, MA
		Address record changed: 2023-07-19

Basic data	Employees	H: 10,001 to 50,00 (2023-07-13)
	Currency	USD
	Annual sales	3,000,000,000 (revenue, annual, consolidated (2022) 2022-12-31)

		* Document for »About Section«: Revvity, Inc.. (7/13/23). "Press Release: Revvity Establishes Scientific Centre of Excellence for Genomic Insight in Cambridge". Cambridge.

		Record changed: 2025-05-29

Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

More documents for Revvity (Group)

[1] Revvity, Inc.. (11/20/24). "Press Release: Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK". Waltham, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)